Measurement of maximal oxygen uptake: clinical applications and prospects

Authors: N.N. Koloskova, K.V. Shatalov, L.A. Bockeria

Company: A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Russian Academy of Medical Sciences


For citation: Koloskova N.N., Shatalov K.V., Bockeria L.A. Measurement of maximal oxygen uptake: clinical applications and prospects. Kreativnaya kardiologiya. 2014; 2: 20-28.

Keywords: cardiopulmonary exercise testing peak VO2 congenital heart disease acquired heart disease pulmonary hypertension

Full text:  

 

Abstract

Today the cardiopulmonary exercise testing (CPET) found broad application in clinical practice, and indications for its application considerably extended. In the review we want to show CPET scopes in clinic and method prospects.

References

1. Колоскова Н.Н., Шаталов К.В., Бокерия Л.А. Определение пикового потребления кислорода: физиологические основы и области
применения. Креативная кардиология. 2014: 1: 48–57.
2. Auricchio Al., Stellbrink C., Butter C. On behalf of the Pacing Therapies in Congestive Heart Failure (PATH-CHF) II Study Group, Kramer
A., Huvelle E., on behalf of the Guidant Heart Failure Research Group. Clinical efficacy of cardiac resynchronization therapy using left
ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J. Am. Coll. Cardiol. 2003; 42: 2109–16.
3. Arora S., Aarones M., Aakhus S., Skaardal R. Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac
resynchronization therapy. J. Cardiol. 2012; 60: 228–35.
4. Колоскова Н.Н., Шаталов К.В., Бокерия Л.А., Тетвадзе И.В. Пиковое потребление кислорода как маркер эффективности
ресинхронизирующей терапии у пациентов с хронической сердечной недостаточностью. Бюллетень НЦССХ им. А.Н. Бакулева
РАМН. 2013; 12 (1): 43–8.
5. Barbara L., Jurgen V., Henning S. Impact of cardiopulmonary exercise testing on patient selection for cardiac resynchronisation therapy.
Eur. Heart J. Supplements. 2004; 6 (Suppl. D): D5–D9.
6. Fredriksen P., Veldtman G., Hechter S., Therrien J. Aerobic capacity in adults with various congenital heart diseases. Am. J. Cardiol. 2001; 1;
87 (3): 310–4.
7. Inuzuka R., Diller G.P., Borgia F., Benson L., Tay E. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital
heart disease at increased mortality risk in the medium term. Circulation. 2012; 125 (2): 250–9.
8. Giardini A., Donti A., Specchia S., Formigari R., Oppido G., Picchio F.M. Long-term impact of transcatheter atrial septal defect closure in
adults on cardiac function and exercise capacity. Int. J. Cardiol. 2008; 124: 179–82.
9. Meadows J., Lang P., Marx G., Rhodes J. Fontan fenestration closure has no acute effect on exercise capacity but improves ventilatory
response to exercise. J. Am. Coll. Cardiol. 2008; 52: 108–13.
10. Dayi S.U., Akbulut T., HobikogКlu G., Akgцz H., Gьrkan U., DagК O. et al. Evaluation of success of mitral valvuloplasty in the early period with
cardiopulmonary exercise test. Anadolu Kardiyol. Derg. 2002; 2: 108–12.
11. Omedи P., Bucca C., Rolla G., Costanzo P., Casoni R., Calachanis M. et al. Cardiopulmonary exercise testing and exhaled nitric oxide in the
assessment of patients with mitral stenosis. Minerva Cardioangiol. 2004; 1: 29–35.
12. Dhoble A., Enriquez-Sarano M., Kopecky S.L., Abdelmoneim S., Cruz P., Thomas R.J., Allison T.G. Cardiopulmonary responses to exercise
and its utility in patients with aortic stenosis. Am. J. Cardiol. 2014; 113 (10): 1711–6.
13. Tan L., Schlosshan D., Lynas P. Value of cardiopulmonary exercise and non-invasive haemodynamic assessment during exercise in patients
with asymptomatic severe aortic stenosis. Heart. 2014; 100 (Suppl. 3): A56–7.
14. Coats C., Rantell K., Bartnik O., Patel A., Mist B., McKenna W., Elliott P. Cardiopulmonary exercise testing and prognosis in hypertrophic
cardiomyopathy. Heart. 2014; 100 (Suppl. 3): A50–1.
15. Azarbal F., Singh M., Finocchiaro G., Le V.V., Schnittger I., Wang P. et al. Exercise capacity and paroxysmal atrial fibrillation in patients with
hypertrophic cardiomyopathy. Heart. 2014; 8: 624–30.
16. Arena R., Owens D., Arevalo J., Smith K., Mohiddin S. Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy. Med.
Sci. Sports Exer. 2008; 40: 799–805.
17. Sharma S., Elliott P.M., Whyte G. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left
ventricular hypertrophy in athletes. J. Am. Coll. Cardiol. 2000; 36: 864–70.
18. Zhao Z.H., Liu Z.H., Gu Q., Luo Q., Zhao Q., Xiong C.M., Ni X.H. Application of cardiopulmonary exercise testing in patients with chronic
thromboembolic pulmonary hypertension. Zhonghua Yi Xue Za Zhi. 2013; 93 (22): 1687–90.
19. Tan X., Yang W., Guo J., Zhang Y., Wu C., Sapkota R. et al. Usefulness of decrease in oxygen uptake efficiency to identify gas exchange abnormality
in patients with idiopathic pulmonary arterial hypertension. PLoS One. 2014; 9 (6): e98889.
20. Arena R., Kathy E. Sietsema cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung diseas. Circulation.
2011; 123: 668.
21. Hoeper M., Faulenbach C., Golpon H., Winkler J., Welte T., Niedermeyer J. Combination therapy with bosentan and sildenafil in idiopathic
pulmonary arterial hypertension. Eur. Respir. J. 2004; 24: 1007–10.
22. William M., Oldham W., Systrom D. Cardiopulmonary exercise testing in the evaluation of unexplained dyspnea advances in pulmonary
hypertension. Official J. Pulmon. Hypertens. Ass. Sum. 2010; 9 (2): 101–7.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery